The Massachusetts Mutual Life Insurance Company recently announced changes to its underwriting policies for breast cancer patients, moves that will ultimately offer more coverage to breast cancer survivors at lower premiums.
The changes come as a response to recent research that changes the staging definitions of breast cancer, reevaluating risk and mortality rates. The previous staging system was somewhat rigid, and included only four stages of invasive and noninvasive breast cancer. The changes establish a more complex framework that better serves women in any stage of diagnosis.
"Ultimately, more breast cancer survivors are now eligible for life insurance, many at reduced premiums," said Valerie R. Kaufman, MD, vice president and chief medical director for MassMutual. "So many people who have battled cancer have told us they do not think they're eligible for insurance or they cannot afford it. As a company, we are proud to dispel this myth."
In an effort to better serve its customers, MassMutual has also updated underwriting policies for prostate and kidney cancer diagnosis. By staying close to the nature of the disease, the company hopes to continually optimize its relationship with its customer base.
The American Cancer Society estimates that 230,480 women in the United States will be diagnosed with invasive breast cancer in 2011.